CVEvulnerability

CVE-2020-27266

6.5 MEDIUM Published 2021-01-19 Modified 2026-06-17 Official page ↗
Status
Modified
Published
2021-01-19
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
6.5 MEDIUM — CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVSS 2.0 ([email protected])
3.3 LOW — AV:A/AC:L/Au:N/C:P/I:N/A:N
Weaknesses
CWE-287, CWE-603

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.

Affected configurations

• sooil anydana-a firmware (< 3.0) • sooil anydana-i firmware (< 3.0) • sooil diabecare rs firmware (< 3.0)

Related

Weakness · CWE (2)

  • CWE-287 Improper Authentication weakness
  • CWE-603 Use of Client-Side Authentication weakness

References